Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NOVAIR is a leading global specialist in on-site medical gas production and distribution systems for healthcare facilities. The company designs and manufactures advanced Pressure Swing Adsorption (PSA) oxygen generators, medical air systems, and medical vacuum units that allow hospitals to achieve autonomy in their gas supply. Headquartered in France and founded in 1977, NOVAIR provides critical infrastructure that supports respiratory therapy, anesthesia, and intensive care units worldwide. Their solutions are deployed in over 150 countries, offering a cost-effective and environmentally friendly alternative to traditional liquid or cylinder gas deliveries. Through its subsidiaries like OGSI and Noxerior, the company maintains a strong international manufacturing and service presence. NOVAIR's technology played a vital role during the COVID-19 pandemic by providing rapid-deployment oxygen solutions to overwhelmed health systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NOVAIR.